aztreonam


Also found in: Dictionary, Medical, Wikipedia.
Related to aztreonam: gentamicin
  • noun

Synonyms for aztreonam

an antibiotic (trade name Azactam) used against severe infections

References in periodicals archive ?
5% patients treated with ceftaroline fosamil and vancomycin plus aztreonam respectively, experiencing[greater than or equal to]1 adverse event.
Aztreonam treatment of Pasleurella multocida cellulitis and bacteremia.
The phenotypic characteristic of ESBLs is concomitant/ simultaneous resistance to aztreonam, cefotaxime, ceftriaxone, and ceftazidime.
In order to know the susceptibility to carbapenems (imipenem and meropenem), ceftazidime and aztreonam as phenotypical indicator substrates of [beta]-lactamases, 30 strains of Pseudomonas aeruginosa (18 from animal clinical samples and 12 from non-chlorinated water) were analysed.
Aztreonam was approved in December 1986 by the FDA as a monobactam, a synthetic bactericidal antibiotic.
ampicillin 10 [micro]g, chloramphenicol 30 [micro]g, amikacin 30 [micro]g, gentamycin 10 [micro]g, ciprofloxacin 30 [micro]g, norfloxacin 10 [micro]g, aztreonam 30 [micro]g, ceftazidime 30 [micro]g, cefotaxime 30 [micro]g, kanamycin 30 [micro]g, nalidixic acid 30 [micro]g, nitrofurantoin 300 [micro]g, cotrimaoxazole 25 [micro]g, triple sulpha 300, tobramycin 10 [micro]g, amoxy-clavulinic acid 30 [micro]g and tetracycline 100 [micro]g (Hi-Media, Mumbai).
Voting 15-2 in favor of Gilead's aztreonam lysine's safety and effectiveness, the FDA panel also voted 17-0 in support of a 75-mg.
The activity of extended spectrum cephalosporins or aztreonam against ESBL producing organisms will be enhanced by the presence of clavulanic acid.
Foster City, CA) has patented a method and a composition for treatment of pulmonary bacterial infections caused by gram-negative bacteria suitable for treatment of infection caused by Escherichia coli, Klebsiella pneumoniae, Klebsiella oxytoca, Pseudomonas aeruginosa, Haemophilus influenzae, Proteus mirabilis, Enterobacter species, Serratia marcescens as well as those caused by Burkholderia cepacia, Stenotrophomonas maltophilia, Alcaligenes xylosoxidans, and multidrug resistant Pseudomonas aeruginosa, using a concentrated formulation of aztreonam lysinate delivered as an aerosol or dry powder formulation.
Aztreonam was given at a dose of 2 g intravenously every 12 hours and could be discontinued after 48 hours at the investigators' discretion.
Ceftazidime versus aztreonam in the treatment of pseudomonal chronic suppurative otitis media in children.
Rib-X recently presented data at ICAAC from a successful Phase 2b study in which delafloxacin met or exceeded primary and secondary efficacy endpoints evaluated in comparison to Zyvox, with and without aztreonam, and vancomycin, with and without aztreonam, including endpoints based on the new draft guidance from the US Food and Drug Administration (FDA) for ABSSSI.